Pyroptosis In Alopecia Areata: Synthesizing Emerging Hypotheses And Charting A Path To New Therapies

    November 2025 in “ Biomedicines ”
    Mateusz Łysek, Justyna Putek, Beata Jastrząb-Miśkiewicz … Piotr K. Krajewski
    Studysummary In this review, researchers reported that pyroptosis, a type of inflammatory cell death linked to inflammasome activity, is a key factor in the pathogenesis of alopecia areata and may present new therapeutic opportunities, though most treatments are still in early research stages.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 45

    1. Immune-Mediated Disorders in Patients With Alopecia Areata: Systematic Review and Meta-Analysis International Journal of Dermatology · 2025
    2. Long-Term Safety and Efficacy of Ritlecitinib in Adults and Adolescents with Alopecia Areata and at Least 25% Scalp Hair Loss: Results from the ALLEGRO-LT Phase 3, Open-Label Study Journal of the European Academy of Dermatology and Venereology · 2025
    3. Comparing the Efficacy of Oral Apremilast, Intralesional Corticosteroids, and Their Combination in Patients With Patchy Alopecia Areata: A Randomized Clinical Controlled Trial Archives of Dermatological Research · 2024
    4. Total Glucosides of Paeony Inhibit NLRP3/Caspase-1/GSDMD-Mediated Inflammation and Pyroptosis in C3H/HeJ Mice With Alopecia Areata Biomolecules and Biomedicine · 2024
    5. Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model International Journal of Molecular Sciences · 2024
    6. Efficacy and Safety of Deuruxolitinib, an Oral Selective Janus Kinase Inhibitor, in Adults with Alopecia Areata: Results from the Phase 3 Randomized, Controlled Trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024
    7. Interleukin-15 Is a Hair Follicle Immune Privilege Guardian Journal of Autoimmunity · 2024
    8. Long-Term Efficacy and Safety of Baricitinib in Patients With Severe Alopecia Areata: 104-Week Results From BRAVE-AA1 and BRAVE-AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    9. Advances In The Mechanism And New Therapies Of Alopecia Areata International journal of rheumatic diseases · 2023
    10. The Crosstalk Between PTEN-Induced Kinase 1-Mediated Mitophagy and the Inflammasome in the Pathogenesis of Alopecia Areata Experimental Dermatology · 2023
    11. Aberrant Inflammasome Activation as a Driving Force of Human Autoimmune Skin Disease Frontiers in immunology · 2023
    12. Topical SCD-153, A 4-Methyl Itaconate Prodrug, For The Treatment Of Alopecia Areata PNAS nexus · 2022
    13. Alopecia Areata and Risk of Atopic and Autoimmune Conditions: Population-Based Cohort Study Clinical and Experimental Dermatology · 2022
    14. Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata International Journal of Molecular Sciences · 2022
    15. Two Phase III Trials of Baricitinib for Alopecia Areata: A Critically Appraised Research Paper British Journal of Dermatology · 2022
    16. Dupilumab for Alopecia Areata Treatment: A Double-Edged Sword? Journal of cosmetic dermatology · 2022
    17. Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata International journal of molecular sciences · 2022
    18. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications Cells · 2021
    19. Hair-Growth Promoting Effect and Anti-Inflammatory Mechanism of Ginkgo Biloba Polysaccharides Carbohydrate Polymers · 2021
    20. Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management Clinical Reviews in Allergy & Immunology · 2021
    21. Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles International journal of molecular sciences · 2021
    22. The Antiinflammatory Effects of Xuefu Zhuyu Decoction on C3H/HeJ Mice With Alopecia Areata Phytomedicine · 2020
    23. Platelet-Rich Plasma in the Treatment of Alopecia Areata: A Review Journal of Investigative Dermatology Symposium Proceedings · 2020
    24. The Effect of JAK Inhibitor on Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells International Journal of Molecular Sciences · 2020
    25. Serum Level of Interleukin-15 in Active Alopecia Areata Patients and Its Relation to Age, Sex, and Disease Severity Advances in Dermatology and Allergology · 2020
    26. JAK Inhibition in the Treatment of Alopecia Areata: A Promising New Dawn? Expert review of clinical pharmacology · 2019
    27. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019
    28. Targeting the Janus Kinase Family in Autoimmune Skin Diseases Frontiers in Immunology · 2019
    29. Efficacy of the Phosphodiesterase-4 Inhibitor, Apremilast, in a Patient with Severe Alopecia Areata European Journal of Dermatology · 2019
    30. Apremilast Is Efficacious in Refractory Alopecia Areata Journal of dermatological treatment · 2019
    31. Pathomechanisms of Immune-Mediated Alopecia International Immunology · 2019
    32. JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2019
    33. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    34. A Randomized Placebo-Controlled Single-Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects with Moderate-to-Severe Alopecia Areata Archives of dermatological research · 2018
    35. Response to Ustekinumab in Three Pediatric Patients with Alopecia Areata Pediatric dermatology · 2018
    36. Alopecia Areata: A Review of Disease Pathogenesis British journal of dermatology/British journal of dermatology, Supplement · 2018
    37. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    38. Double-Stranded RNA Induces Inflammation via the NF-κB Pathway and Inflammasome Activation in the Outer Root Sheath Cells of Hair Follicles Scientific reports · 2017
    39. Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients Annals of dermatology/Annals of Dermatology · 2017
    40. Alopecia Areata: Animal Models Illuminate Autoimmune Pathogenesis and Novel Immunotherapeutic Strategies Autoimmunity reviews · 2016
    41. Extensive Alopecia Areata Is Reversed by IL-12/IL-23p40 Cytokine Antagonism The Journal of Allergy and Clinical Immunology · 2015
    42. Alopecia Areata Profiling Shows TH1, TH2, and IL-23 Cytokine Activation Without Parallel TH17/TH22 Skewing ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology · 2015
    43. Inhibiting Janus Kinases to Treat Alopecia Areata Nature medicine · 2014
    44. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    45. A Randomized, Double-Blind, Placebo- and Active-Controlled, Half-Head Study to Evaluate the Effects of Platelet-Rich Plasma on Alopecia Areata British Journal of Dermatology · 2013